Tell your health care provider about your medical history prior to taking Saxenda
From there, a licensed clinician will evaluate your results and determine eligibility
Phase 2 Type 2 Diabetes Trial: Rosenstock J, Frias J, Jastreboff AM, et al
Secondary endpoints included change in BMI, HbA1c, lipid profile, hs-CRP, and liver enzymes
The Congressional Budget Office (CBO) has stated, "The developing market for [anti-obesity medications] could significantly affect health care spending and the federal budget." They contend that passage of the Treat and Reduce Obesity Act would increase costs for anti-obesity medications (i.e., because more people would use them) but reduce federal costs for other related health issues